Physician

Rishi Vora, D.O.

According to 2025 Medicare claims, Rishi Vora, D.O. (NPI: 1730575119) practices physical medicine and rehabilitation in the Eugene-Springfield, OR market, with the plurality of this provider's patient population coming from Lane, OR. This provider's primary affiliated billing organization is PACIFIC SPORTS AND INTERVENTIONAL SPINE, LLC (NPI: 1881186336; TIN: 830696052) and primary practice location at 97404-5429. Vora is affiliated with the Innovation Care Partners MSSP (ACO ID: A2029), participating under the MSSP model.

Vora's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 357 traditional Medicare patients, billed 6,860 HCPCS/CPT codes, and received $188,497 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,148 prescription claims across 207 beneficiaries totaling $27,652 in drug costs, led by Buprenorphine Hcl (Buprenorphine Hcl). Open Payments data shows 66 records totaling $1,485. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $5,384 to $27,652. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	103	368	$24,182
2020	361	3,186	$159,169
2021	477	3,883	$239,997
2022	603	4,347	$258,727
2023	370	2,373	$191,931
2024	357	6,860	$188,497

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	23	83	$5,384
2017	18	65	$3,220
2018	25	55	$1,130
2019	111	274	$5,662
2020	183	1,342	$47,077
2021	231	1,872	$81,694
2022	274	1,611	$74,749
2023	204	1,420	$67,877
2024	207	1,148	$27,652

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	96	96	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	190	343	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	99	129	$65
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	214	326	$12
J1010	Injection, methylprednisolone acetate, 1 mg	75	4,400	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Buprenorphine Hcl	Buprenorphine Hcl	84	2,431	$3,873
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	133	3,226	$3,594
Buprenorphine	Buprenorphine	13	364	$3,484
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	69	1,843	$2,138
Morphine Sulfate Er	Morphine Sulfate	61	1,735	$1,596

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	66	$1,485	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rishi Vora, D.O.?

Tedicare shows public-source Medicare data for Rishi Vora, D.O. (NPI 1730575119), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rishi Vora, D.O. have ACO affiliation data?

Rishi Vora, D.O. is shown with ACO affiliation data for Innovation Care Partners MSSP (MSSP, ACO ID A2029).

What billing organization is linked to Rishi Vora, D.O.?

Rishi Vora, D.O. is linked to PACIFIC SPORTS AND INTERVENTIONAL SPINE, LLC (billing NPI 1881186336) in the available physician profile data.

Does Rishi Vora, D.O. have Open Payments data?

Rishi Vora, D.O. has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.